Cargando…
Management of acromegaly
Acromegaly is caused by hypersecretion of growth hormone and resultant overproduction of insulin-like growth factor-1 and is associated with increased mortality and morbidity. Successful treatment modalities have been developed and are used in a multistep approach allowing normal life expectancy as...
Autores principales: | Vasilev, Vladimir, Daly, Adrian, Zacharieva, Sabina, Beckers, Albert |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Medicine Reports Ltd
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2990454/ https://www.ncbi.nlm.nih.gov/pubmed/21173856 http://dx.doi.org/10.3410/M2-54 |
Ejemplares similares
-
Clinical and genetic aspects of familial isolated pituitary adenomas
por: Vasilev, Vladimir, et al.
Publicado: (2012) -
Case Report: A case report of acromegaly associated with primary aldosteronism
por: Matrozova, Joanna, et al.
Publicado: (2014) -
Thyroid gland changes in patients with acromegaly
por: Natchev, Emil, et al.
Publicado: (2020) -
Acromegaly at diagnosis in 3173 patients from the Liège Acromegaly Survey (LAS) Database
por: Petrossians, Patrick, et al.
Publicado: (2017) -
Primary hypertrophic osteoarthropathy due to a novel
SLCO2A1 mutation masquerading as acromegaly
por: Mangupli, Ruth, et al.
Publicado: (2017)